Ras homolog enriched in brain (Rheb) is a small GTPase that regulates cell growth, differentiation, and survival by upregulating mammalian target of rapamycin complex 1 (mTORC1) signaling. The role of Rheb/ mTORC1 signaling in the activation of kidney fibroblasts and the development of kidney fibrosis remains largely unknown. In this study, we found that Rheb/mTORC1 signaling was activated in interstitial myofibroblasts from fibrotic kidneys. Treatment of rat kidney interstitial fibroblasts (NRK-49F cell line) with TGFb1 also activated Rheb/mTORC1 signaling. Blocking Rheb/mTORC1 signaling with rapamycin or Rheb small interfering RNA abolished TGFb1-induced fibroblast activation. In a transgenic mouse, ectopic expression of Rheb activated kidney fibroblasts. These Rheb transgenic mice exhibited increased activation of mTORC1 signaling in both kidney tubular and interstitial cells as well as progressive interstitial renal fibrosis; rapamycin inhibited these effects. Similarly, mice with fibroblast-specific deletion of Tsc1, a negative regulator of Rheb, exhibited activated mTORC1 signaling in kidney interstitial fibroblasts and increased renal fibrosis, both of which rapamycin abolished. Taken together, these results suggest that Rheb/mTORC1 signaling promotes the activation of kidney fibroblasts and contributes to the development of interstitial fibrosis, possibly providing a therapeutic target for progressive renal disease.
CKD affects approximately 10% of the population worldwide. Most patients who suffer from CKD inevitably progress to end stage renal failure. The major pathologic feature of CKD is renal interstitial fibrosis characterized by extracellular matrix (ECM) deposition in kidney tissue with different scales, which is closely correlated with renal dysfunction. 1, 2 Many cell types in the kidney, such as fibroblasts, tubular epithelial cells, and pericytes, are able to produce ECM and contribute to renal fibrosis. Among them, fibroblasts play an important role for kidney ECM deposition and renal fibrosis upon activation. 1, [3] [4] [5] [6] Fibroblasts stay in the kidney interstitium and maintain the homeostasis of interstitial matrix and adjacent tissue under physiologic conditions through matrix production, cytokine secretion, and direct contact with other cells such as tubular epithelial cells and endothelial cells. 1, 7 Upon stimulation with profibrotic factors, fibroblasts may be activated and acquire the myofibroblast phenotype through expressing a-smooth muscle actin (a-SMA) and other markers. [8] [9] [10] Myofibroblasts can produce a large amount of ECM and are a major determining factor controlling the progression of renal fibrosis and the decline of kidney function. Several profibrotic factors, including TGFb1, fibroblast growth factor 2, platelet-derived growth factor, connective tissue growth factor, and tissue plasminogen activator, have been identified in promoting fibroblast activation. [11] [12] [13] [14] [15] [16] However, the intracellular molecular mechanisms regulating fibroblast activation remain largely unknown. In light of the critical role of fibroblast activation in initiating and promoting kidney fibrosis, delineation of the underlying mechanism for renal fibroblast activation is essential in unraveling the pathogenic mechanism of renal fibrosis and in developing rational intervention strategies.
The Ras homolog enriched in the brain gene (Rheb) is ubiquitously expressed in mammalian cells. Its encoded protein plays an important role in regulating cell growth and survival. [17] [18] [19] [20] Similar to other reported small GTPases, Rheb exists either in an active guanosine triphosphate (GTP)-bound state or an inactive guanosine diphosphate (GDP) -bound state and Rheb-GTP activates the target of rapamycin complex 1 (TORC1). 21, 22 Rheb is negatively regulated by the Tsc1/Tsc2 complex and ablation of Tsc1 or Tsc2 leads to activation of Rheb and its downstream signaling pathway. 23 TORC1 consists of several protein components, including the mammalian target of rapamycin (mTOR) itself, the regulatory-associated protein of mTOR (Raptor), and mLST8. TORC1 regulates cell growth through phosphorylating several downstream targets such as p70 S6 kinase (S6K) and the eukaryotic initiation factor 4E (eIF4E)-binding proteins 1 and 2 (4E-BP1 and 4E-BP2). [24] [25] [26] [27] [28] Abnormal activation of mTORC1 is involved in the pathogenesis of polycystic kidney disease, diabetic nephropathy, [29] [30] [31] [32] [33] [34] [35] podocyte dysfunction, and kidney fibrosis. [36] [37] [38] [39] [40] However, most previous reports are based on the application of rapamycin, a reagent originally considered an mTORC1-specific inhibitor, which may stimulate other effects besides fibroblasts and mTORC1. 41, 42 Thus, whether Rheb/mTORC1 activation can stimulate kidney fibroblasts and interstitial fibrosis in CKD remains to be defined.
Here we report that Rheb/mTORC1 signaling is activated in both fibrotic kidney myofibroblasts and TGFb1-treated kidney fibroblast cell lines. Rheb overexpression can initiate kidney fibrosis. Inhibition of Rheb/mTORC1 signaling is able to ameliorate kidney fibrosis in Rheb transgenic mice. Specific deletion of Tsc1 in fibroblasts leads to mTORC1 signaling activation and kidney fibrosis in mice. This study provides novel mechanistic insight into the pathogenic role for Rheb/mTORC1 signaling in fibroblast activation and kidney fibrosis.
RESULTS

Activation of Rheb/mTORC1 Signaling in Interstitial Myofibroblasts from Fibrotic Kidneys
To investigate the activation of Rheb/mTORC1 signaling in kidney interstitial cells, we created a mouse kidney fibrosis model by unilateral ureteral occlusion (UUO). Similarly to previous reports, 9,11 UUO kidneys developed severe interstitial fibrosis at days 7 and 14 after surgery (data not shown). Compared with sham controls, Rheb and p-4E-BP protein were sharply induced in the fibrotic kidneys at days 7 and 14 after surgery ( Figure 1, A and B) . To further identify the cell types in which Rheb/mTORC1 was activated, an immunohistochemical staining assay for Rheb and p-4E-BP was deployed. Very weak staining of Rheb and p-p4E-BP could be detected in tubular epithelial cells, but not in interstitial cells, in sham controls. However, in UUO kidneys, both Rheb and p-4E-BP staining were markedly enhanced in tubular cells as well as in interstitial cells ( Figure 1C ). Costaining the kidney tissues with anti-laminin and anti-p-4E-BP antibody, or anti-laminin and anti-Rheb antibody, respectively, showed that interstitial cells expressed p-4E-BP and Rheb after UUO ( Figure 1E ). Double immunofluorescence revealed that p-4E-BP and Rheb were induced in kidney interstitial a-SMA-positive cells (Figure 1, D and E) . Taken together, these data suggest that mTORC1 signaling was activated in myofibroblasts in the UUO kidneys. Furthermore, macrophage infiltration was also increased in the UUO kidneys (Supplemental Figure 3) .
In normal human kidneys, there was little staining of Rheb and p-4E-BP in tubular and interstitial cells. In fibrotic kidneys from patients with diabetic nephropathy, both Rheb and p-4E-BP-positive cells could be detected in interstitial cells as well as in tubules ( Figure 1F ).
Rheb/mTORC1 Signaling Activation Mediates TGFb1-Induced Fibroblast Activation
To further evaluate the role of Rheb/mTORC1 signaling in kidney fibroblast activation, NRK-49F cells, a rat kidney interstitial fibroblast cell line, were treated with TGFb1. After TGFb1 treatment, except for the induction of the GTP loading Rheb (Figure 2 , A and B), Rheb mRNA and protein expression was also remarkably induced ( Figure 2 , C and D, and Supplemental Figure 1 ). Blockade of the gene transcription or translation with actinomycin D or cycloheximide (CHX), respectively, inhibited Rheb protein induction by TGFb1, suggesting that the induction of Rheb by TGFb1 may be through transcriptional stimulation (Supplemental Figure 1) . mTORC1 signaling molecules including p-mTOR, p-p70 S6K, p-S6, and p-4E-BP were all stimulated at as early as 1 hour and reached peak at 12 hours. Except for p-4E-BP, all of the others declined after 12 hours ( Figure 2C ). Immunofluorescence also showed that p-p70 S6K, p-4E-BP, and p-S6 were increased and primarily localized in the cytosol after TGFb1 treatment ( Figure 2E ). Pretreatment of NRK-49F cells with rapamycin 30 minutes before TGFb1 administration significantly inhibited TGFb1-induced mTORC1 activation ( Figure 3A) . Furthermore, TGFb1-induced fibronectin (FN) and a-SMA expression was also decreased by the addition of rapamycin (Figure 3, B-F) . The cell viability exhibited as the lactate dehydrogenase level in supernatant was similar among the groups (data not shown).
Small interfering RNA (siRNA) was used to decrease Rheb expression in NRK-49F cells. Rheb siRNA could significantly reduce Rheb protein expression ( Figure 4, A and B) . Similar to rapamycin treatment, the reduction of Rheb expression also blocked TGFb1-induced mTORC1 signaling and fibroblast activation ( Figure 4 , C-F). Cell viability was similar among the groups (data not shown). Taken together, these results suggest that activation of Rheb/mTORC1 signaling is required for TGFb1-induced fibroblast activation.
We also created Rheb transgenic mice and established primary cultured kidney fibroblasts from these transgenic mice. The primary cultured fibroblasts were identified by anti-vimentin and anti-Fsp1 staining (Supplemental Figure 2) . Compared with fibroblasts from wild-type mice, Rheb transgenic fibroblasts exhibited activation of mTORC1 signaling in these cells ( Figure 5A ). Treatment with rapamycin could largely abolish these effects as well as the increased expression of FN and a-SMA in Rheb transgenic cells, suggesting that Rheb/mTORC1 signaling is critical for promoting fibroblast activation ( Figure 5 , B-E).
Rheb Transgenic Mice Exhibit Activated mTORC1 Signaling and Progressive Kidney Fibrosis
All of the Rheb transgenic mice were born normal. At 6 months after birth, there was no significant change as to kidney weight, kidney function, urinary albumin, or Nacetyl-b-D-glucosaminidase (NAG) enzyme between Rheb transgenic mice and their control littermates (Table 1 ). In in vivo assessment, both Rheb mRNA and protein expression were upregulated in the whole Rheb transgenic kidney tissue ( Figure 6A ). Phosphorylated 4E-BP and p70 S6K were increased in kidney tissues, indicating the activation of Rheb/mTORC1 signaling in kidneys from transgenic mice ( Figure 6B ). In Rheb transgenic mice, total collagen, FN, and a-SMA expression levels were increased in the kidney tissue at 1 month of age and further increased at 3 and 6 months of age ( Figure 6 , C-E). Under a light microscope, the kidney histologic change was minor. However, Masson, Sirius red, FN, and a-SMA staining showed that Rheb transgenic mice exhibited focal kidney interstitial ECM accumulation and fibrosis in the cortical area ( Figure 6F ). Macrophage infiltration was slightly increased in the kidneys of transgenic mice (Supplemental Figure 3) . Taken together, these results indicate that Rheb transgenic mice can activate mTORC1 signaling and initiate kidney fibrosis in mice.
To further assess the effect of mTORC1 signaling on Rheb transgenic-induced kidney fibrosis, the Rheb transgenic mice were treated with rapamycin at approximately 1 month of age and were euthanized 3 months after birth. Rapamycin could inhibit mTORC1 signaling in the kidney tissues ( Figure 7 , A and B). Rapamycin could also significantly inhibit FN and a-SMA expression and collagen accumulation in the transgenic kidneys ( Figure 7 , C-E). Masson, Sirius red, FN, and a-SMA staining showed that rapamycin could inhibit kidney fibrosis in the Rheb transgenic mice ( Figure 7F ).
Fibroblast-Tsc1
2/2 Mice Exhibit Kidney Interstitial Fibroblast Activation and Kidney Fibrosis In view of the role of Tsc1 in negatively regulating Rheb activity, we created conditional knockout mice in which the Tsc1 gene was specifically deleted in fibroblasts by using the Cre-LoxP system ( Figure 8A ). Western blot analysis demonstrated that the Tsc1 protein was decreased, whereas the p-4E-BP level was induced in the kidney tissue from Fibroblast-Tsc1 2/2 mice, compared with those from control littermates ( Figure 8C ). The mice were born normal, and there was no difference in body weight in Fibroblast-Tsc1 2/2 mice at 2 weeks of age compared with control littermates. However, a significant reduction in body weight was found in Fibroblast-Tsc1 mice died between 3 and 4 weeks after birth; however, most of the other survived mice would stay alive at least to 4 months after birth. At 4 months after birth, the knockout mice exhibited significantly increased urinary NAG output compared with their control littermates. Serum creatinine, BUN, and urinary albumin excretion were not significantly increased (Table 1) .
To further identify the cell types in which Tsc1 was deleted and mTORC1 was activated in the knockout mice, we utilized costaining of Fsp1 with Tsc1 or with p-4E-BP. Costaining of Fsp1 with Tsc1 showed that Tsc1 could be detected in Fsp1-positive cells in controls, whereas Tsc1 staining was negative in Fsp1-positive cells in FibroblastTsc1 2/2 mice, indicating specific deletion of Tsc1 in fibroblasts ( Figure 8D ). Similarly, costaining of Fsp1 with p-4E-BP showed that p-4E-BP was remarkably induced in Fsp1-positive cells from Fibroblast-Tsc1 2/2 kidneys. Immunohistochemical staining showed that p-4E-BP was increased in kidney interstitial cells ( Figure 8D ). Taken together, these data demonstrate the specific mTORC1 signaling activation in fibroblasts in Fibroblast-Tsc1 2/2 mice. There was no obvious kidney fibrosis in Fibroblast-Tsc1
mice at 2 and 4 weeks of age. However, FN protein abundance was significantly induced in the kidney tissue from FibroblastTsc1 2/2 mice compared with control littermates at 1 month after birth ( Figure 8E ). Total collagen and injured tubules were significantly increased in Fibroblast-Tsc1 Figure 8I ). Macrophage infiltration was slightly increased in the kidneys from knockout mice (Supplemental Figure 3) . Taken together, these results demonstrate that mTORC1 signaling activation in fibroblasts can promote fibroblast activation and kidney fibrosis.
At approximately 2 months of age, knockout mice were treated with rapamycin for 2 months. Rapamycin could inhibit mTORC1 signaling in knockout kidneys ( Figure 9, A and B) . Collagen accumulation, tubule damage, and FN expression were also ameliorated by rapamycin administration in the kidneys of knockout mice ( Figure 9 , C-E).
DISCUSSION
This study shows that Rheb/mTORC1 signaling is activated in myofibroblasts from fibrotic kidneys. TGFb1 can stimulate this signaling and the blockade of it abolishes fibroblast activation. Ectopic expression of Rheb promotes fibroblast activation and ECM production. Specific deletion of Tsc1 in fibroblasts induces kidney interstitial fibrosis. To our knowledge, this is the first study to investigate the effect of Rheb/mTORC1 signaling in fibroblast activation by utilizing Rheb transgenic mice and fibroblast-specific mTORC1 activation models. This study provides novel mechanistic insight into the pathogenic role for Rheb/mTORC1 signaling in fibroblast activation and kidney fibrosis.
The TOR complex can be divided into mTORC1 and mTORC2 based on their composition. 24, 43 A large body of literature has proven the essential role of this complex, especially mTORC1, in regulating many biologic processes, including development, tumor genesis, inflammation, and tissue fibrosis. 20, 22, [25] [26] [27] [28] [29] 40, [44] [45] [46] Inhibition of mTORC1 delays or even reverses glomerular disease and renal fibrosis in many renal disease models such as FSGS, membranous nephropathy, and obstructive nephropathy. 12, 31, 32, 34, 39, 42, 47, 48 Chen et al. recently used rapamycin to treat a UUO model and found that rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts, which raised a possible role for myofibroblast mTORC1 activation in promoting kidney fibrosis. 49 However, all of these conclusions raised by previous studies were primarily obtained through administration of rapamycin, which has some other effects except for acting as an inhibitor of mTORC1. 30, 42, 50 In addition, except for fibroblasts, many other cell types, such as tubular cells, vascular endothelial cells, and infiltrating cells, may also contribute to kidney fibrosis. Thus, it is critical to identify the specific cell types in which mTORC1 activation contributes to kidney fibrosis. 18, 51, 52 In this study, we found that Rheb/mTORC1 signaling was activated in interstitial cells from kidneys with obstructive nephropathy or diabetic nephropathy. In addition, Rheb transgenic mice developed mild but progressive fibrotic kidney disease with age, suggesting a direct profibrotic effect of Rheb/mTORC1 signaling in kidneys.
Rheb exists either in an active GTP-bound state or an inactive GDP-bound state. 17 In this study, we found that Rheb was induced in interstitial cells and fibroblast under diseased conditions. We also detected its downstream signaling target to show the active state of induced Rheb. In Rheb transgenic mice, there is no obvious phenotype change as to the birth rate and life cycle during the observation period. Although Rheb was not specifically expressed in kidney interstitial fibroblasts in this transgenic model, the results from the in vivo studies are consistent with the cellular observations. TGFb1 could directly activate Rheb/mTORC1 signaling in fibroblasts. p-mTOR, p-p70 S6K, and p-S6 were induced and maintained at high levels to 12 hours but declined after that, whereas p-4E-BP was increased during the observation period. This may be due to the t 1/2 difference for the phosphorylated molecules. Phosphorylated 4E-BP may be more difficult to de-phosphorylate than the others. Pharmacologic inhibition of mTORC1 signaling with rapamycin or specific targeting of Rheb using siRNA could abolish these effects. When combined, they support the concept that activation of Rheb/mTORC1 signaling activation plays a critical role for fibroblast activation and kidney fibrosis.
Myofibroblasts, an activated form of fibroblasts, can be differentiated from several cell types, including fibroblasts, tubular epithelial cells, pericytes, and endothelial cells under specific conditions. Myofibroblasts are the major source for kidney interstitial ECM and plays a detrimental role in promoting kidney fibrosis. Fibroblasts, usually residing in the kidney interstitium, are believed to be the major source of myofibroblasts and play an essential role in maintaining homeostasis of interstitial matrix and adjacent tissues under physiologic conditions through matrix production, cytokine secretion, and direct contact with the other cell types. 1 Upon activation by various profibrotic factors, fibroblasts can be activated and acquire the myofibroblast phenotype through expressing a-SMA and other markers. Several intracellular signaling pathways, such as Smad signaling and integrin-linked kinase (ILK), may be involved in this process. Targeting these signaling pathways may retard fibroblast activation and provide some beneficial effects for ameliorating kidney fibrosis. 8, 11 Recently, accumulating evidence demonstrated the critical role of mTORC1 in regulating cell growth and differentiation. 12, 23, 53 However, whether mTORC1 is directly involved in kidney fibroblast activation remains to be defined. The central hypothesis of this study is that Rheb/mTORC1 signaling activation is important for kidney fibroblast activation and targeting this signaling pathway may retard fibroblast activation and ameliorate kidney fibrosis. To explore this hypothesis, we treated NRK-49F cells with TGFb1 and found that Rheb/mTORC1 signaling was activated. Using Rheb transgenic mice, we found interstitial fibroblast activation with little tubular epithelial cell damage, which supports the concept that fibroblast activation contributes to interstitial fibrosis. In this study, we also generated a mouse model of a fibroblast-specific deletion of Tsc1 through the Cre-LoxP system. A mouse model expressing Cre driven by S100a4 promoter, was used in this study. 54 We found that Fibroblast-Tsc1 2/2 mice exhibited mTORC1 signaling activation in kidney interstitial cells and focal kidney interstitial fibrosis. Rapamycin treatment largely abolished kidney fibrosis in the knockout mice, which provides solid evidence of the profibrotic role for Rheb/ mTORC1 activation in fibroblasts and kidney fibrosis.
In summary, this study established that Rheb/mTORC1 signaling mediates the fibrogenic process that promotes fibroblast activation and kidney interstitial fibrosis. Targeting this mechanism may prove beneficial to the patients with fibrotic kidney diseases.
CONCISE METHODS
Mice and Animal Models
Male C57BL/6J mice weighing approximately 18-22 g were acquired from the Specific Pathogen-Free Laboratory Animal Center of Nanjing Medical University and maintained according to the guidelines of the Institutional Animal Care and Use Committee at Nanjing Medical University. UUO was performed as previously reported. 11 The mice were euthanized at days 7 and 14 after UUO, and the UUO as well as the contralateral kidneys were removed. One portion of the kidney was fixed in 10% phosphate-buffered formalin followed by paraffin embedding for histologic and immunohistochemical staining. Another portion was immediately frozen in Tissue-Tek optimum cutting temperature compound (Sakura Finetek, Torrance, CA) for cryosection. The remaining kidney tissue was snap-frozen in liquid nitrogen and stored at -80°C for extraction of RNA and protein.
pCAG-Rheb transgenic mice with a C57BL/ 6 background were generated at Nanjing Medical University. pCAG-Rheb transgenic mice and control littermates were euthanized at 4 weeks, 12 weeks, and 24 weeks, respectively, after birth and kidney tissue was harvested for further analysis. Urine and blood samples were collected at 6 months after birth for the determination of urinary NAG, albumin, and kidney function. Rapamycin was given intraperitoneally at a dosage of 2.5 mg/kg per day for 8 weeks in a group of pCAG-Rheb transgenic mice (age 4-5 weeks). The fibroblast-specific Tsc1 knockout mice with mixed genetic background were generated by crossbreeding Tsc1-floxed mice (C57BL/6J background; Jackson Laboratory, Bar Harbor, ME) with S100a4-Cre transgenic mice (BALB/ cByJ background; Jackson Laboratory). 55, 56 By mating Tsc1-floxed mice with S100a4-Cre transgenic mice, mice that were heterozygous for the Tsc1-floxed allele were generated (genotype: Tsc1 fl/wt , Cre +/2 ). These mice were bred Urine and blood samples were collected at 4 months after birth for further examination. For pharmacologic treatment, knockout mice were treated with rapamycin at 2 months of age at a dosage of 2.5 mg/kg per day intraperitoneally for 2 months.
Cell Culture and Treatment
Rat kidney interstitial fibroblasts (NRK-49F) cells were obtained from American Type Culture Collection (Manassas, VA). Cells were cultured in DMEM-F12 medium supplemented with 10% FBS (Invitrogen, Grand Island, NY). The cells were seeded on six-well culture plates to 60%-70% confluence in complete medium containing 10% FBS for 16 hours, and then changed to serum-free medium after washing twice with serum-free medium. Human recombinant TGFb1 (category 100-B-010-CF; R&D Systems, Minneapolis, MN) was added to the serum-free medium for various periods of time. Rapamycin (cat: R8781; Sigma-Aldrich, St. Louis, MO) was added at concentrations of 0.5 nM, 1 nM, and 5 nM 30 minutes before TGFb1 stimulation. Rheb siRNA (GenePharma, Shanghai, China) was transfected into NRK-49F cells using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions. Primary renal interstitial fibroblasts were isolated from pCAGRheb mice or control littermates as previously reported. 57 Briefly, mice were euthanized at 2 weeks of age, and the kidneys were immediately removed and placed in cold HBSS (Invitrogen Corporation, Carlsbad, CA) with 1% antibiotic/antimycotic (Sigma-Aldrich). After pressing through a 50 mesh sieve, the suspension was centrifuged at 10003g for 10 minutes and the precipitation was resuspended in DMEM-F12 medium supplemented with 10% FBS (Invitrogen). The medium was changed at day 3. The cells were passaged normally and seeded on six-well cultural plates to 60%-70% confluence in complete medium containing 10% FBS and cultured for 16 hours, and then changed to serum-free medium after washing twice with serum-free medium. The primary cultured fibroblasts were identified by anti-vimentin and anti-Fsp1 staining (NB100-55404; Novus Biologicals, Littleton, CO). For rapamycin treatment, the reagent was added at a concentration of 5 nM.
Histology and Immunohistochemistry
Human kidney specimens were obtained from diagnostic renal biopsies performed at the Second Affiliated Hospital of Nanjing Medical University. Nontumor kidney tissue from patients with renal cell carcinoma who underwent nephrectomy was used as the control. The Institutional Review Board at the Second Affiliated Hospital approved all studies involving human tissues. Mouse kidney samples were fixed in 10% neutraformaline and embedded in paraffin. Sections 3 mM in thickness were used for Masson and Sirius red staining. Paraffin-embedded kidney sections were deparaffinized, hydrated, and antigen-retrieved, and endogenous peroxidase activity was quenched by 3% H 2 O 2 . Sections were then blocked with 10% normal donkey serum, followed by incubating with anti-Rheb (cat: ab92313; Abcam, Cambridge, UK), anti-p-p70 S6K (Thr421/Ser424) (cat: 9204, Cell Signaling Technology, Beverly, MA), or anti-p-4E-BP (Thr37/46) (cat: 2855; Cell Signaling Technology) overnight at 4°C. After incubation with secondary antibody for 1 hour, sections were incubated with avidin: biotinylated enzyme complex (ABC) reagents for 1 hour at room temperature before being subjected to substrate 3-amino-9-ethylcarbazole for staining (Vector Laboratories, Burlingame, CA). Slides were viewed with a Nikon Eclipse 80i microscope equipped with a digital camera (DS-Ri1; Nikon Instruments Inc, Melville, NY).
Immunofluorescence
We fixed 3-mm kidney cryosections for 15 minutes in 4% paraformaldehyde, followed by permeabilization with 0.2% Triton X-100 in PBS for 5 minutes at room temperature. After blocking with 2% donkey serum for 60 minutes, slides were immunostained with primary antibodies against a-SMA (Sigma-Aldrich), Fsp1, p-4E-BP (Thr37/46), or Tsc1 (cat: 6935; Cell Signaling Technology). To visualize the primary antibodies, slides were stained with FITC-or TRITC-conjugated secondary antibodies. Cells cultured on coverslips were washed twice with cold PBS and fixed with cold methanol/acetone (1:1) for 10 minutes at 220°C. After three extensive washings with 13PBS, the cells were treated with 0.1% Triton X-100 for 5 minutes and blocked with 2% normal donkey serum in PBS buffer for 40 minutes at room temperature and incubated with the anti-active Rheb (cat: 26910; NewEast Biosciences, Malvern, PA), anti-p-p70 S6K (Thr421/Ser424), anti-p-4E-BP (Thr37/46), anti-p-S6 (S235/236), anti-FN (Sigma-Aldrich), or anti-a-SMA (SigmaAldrich), followed by staining with FITC-or TRITC-conjugated secondary antibody. Cells were also stained with 49,6-diamidino-2-phenylindole to visualize the nuclei. Slides were viewed with a Nikon Eclipse 80i Epifluorescence microscope equipped with a digital camera.
Western Blot Analyses
Cultured NRK-49F cells or primary cultured kidney fibroblasts were lysed in 13SDS sample buffer. The kidney were lysed with RIPA solution containing 1% NP40, 0.1% SDS, 100 mg/ml PMSF, 1% protease inhibitor cocktail, and 1% phosphatase I and II inhibitor cocktail (SigmaAldrich) on ice. The supernatants were collected after centrifugation at 13,0003g at 4°for 30 minutes. Protein concentration was determined by bicinchoninic acid protein assay (BCA Protein Assay Kit; Pierce Thermo-Scientific, Rockford, IL) according to the manufacturer's instructions. An equal amount of protein was loaded into 10% or 15% SDS-PAGE and transferred onto polyvinylidene difluoride membranes. The primary antibodies used were as follows: anti-Rheb, anti-p-p70 S6K (Thr421/ Ser424), anti-p-4E-BP (Thr37/46), anti-p-S6, anti-FN, anti-a-SMA, and anti-b-actin (Sigma-Aldrich). Quantification was performed by measurement of signal intensity with ImageJ software (National Institutes of Health, Bethesda, MD).
Measurement of Rheb Activation in Cultured NRK-49F Cells
The active GTP-bound Rheb in cultured NRK-49F cells was determined as previously reported. 58, 59 Briefly, NRK-49F cells were treated with TGFb1 (2 ng/ml) for the different time points as indicated. Cells were harvested and extracted in an ice-cold HEPES-based buffer containing 10 mM MgCl 2 , protease inhibitors, and 1% Nonidet P-40. The total Rheb in the extraction was precipitated with the antiRheb antibody. After shaking for 16 hours at 4°C, the beads were washed four times with The beads were resuspended in 20 mM TrisPO4, 1 mM DTT, and 1 mM EDTA, and heated at 100°C for 3 minutes to elute GTP and GDP bound to the precipitated Rheb. GTP was converted to ATP by a nucleoside diphosphate kinase in the presence of excess ADP with the resulting ATP measured with the ATP Bioluminescent Assay Kit (product number: FL-AA; Sigma-Aldrich). The sum of GTP plus GDP was measured by converting GDP to GTP using pyruvate kinase and phosphoenolpyruvate and then the total GTP, which represents the sum of GDP plus GTP, was measured as described above. The result was presented as the ratio of GTP to GTP plus GDP.
Quantitative Determination of Collagen in Kidney Tissue
The kidney tissue collagen was quantitated as previously reported. 60 Briefly, 3-mm sections of paraffin-embedded tissue were stained with Sirius red F3BA and Fast Green FCF (Sigma-Aldrich) overnight. After washing three times with 13PBS buffer, the dye was eluted from tissue sections with 0.1 N sodium hydroxide methanol. Absorbances of 540 and 605 nm were determined for Sirius red F3BA and Fast Green FCF binding protein, respectively. This assay provided a simple, relative measurement of the ratio of collagen to total protein, which was expressed as micrograms per milligram of total protein.
RNA Isolation and Real-Time Quantitative RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer's instructions. cDNA was synthesized using 1 mg of total RNA, ReverTra Ace (Toyobo, Osaka, Japan), and oligo (dT) 12-18 primers. Gene expression was measured by real-time PCR using real-time PCR Master Mix reagents (Roche, Berlin, Germany) and 7300 real-time PCR system (Applied Biosystems, Foster City, CA). For real-time PCR analysis, the relative amount of mRNA or gene to internal control was calculated using the equation 2
△CT
, in which △C T = C T gene 2 C T control .
Urinary Albumin, Creatinine, and NAG Assay Urinary albumin level was measured by using a mouse Albumin ELISA quantification kit, according to the manufacturer's protocol (Bethyl Laboratories, Montgomery, TX). Urinary creatinine was determined by using a QuantiChrom creatinine assay kit according to the protocol (DICT-500; BioAssay Systems, Hayward, CA). Urinary NAG was detected by using a NAG assay kit according the manufacturer's protocol (Nanjing Jiancheng Bioengineering Inc, Nanjing, China).
Statistical Analyses
All data are presented as the mean 6 SEM. Statistical analysis of the data was performed using SigmaStat software (Jandel Scientific Software, San Rafael, CA). Comparison between groups was made using one-way ANOVA, followed by the Student-Newman-Keuls test. P,0.05 was considered statistically significant. PAS, periodic acid-Schiff.
